These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 1470278

  • 1. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG.
    Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M.
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK, Rubin J, Harvey J.
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC, Eisenberg JD, Wagener JS, Ahrens R, Rock M, doPico G, Orenstein DM.
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [Abstract] [Full Text] [Related]

  • 5. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
    Santini B, Ivaldi AP.
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
    [Abstract] [Full Text] [Related]

  • 6. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW, Stern RC, Trout JR, Sherman JM, Eigen H, Wagener JS, Duggan C, Wohl ME, Colin P.
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1365-71. PubMed ID: 15606399
    [Abstract] [Full Text] [Related]

  • 7. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D, Ellis L, Corey M, Pencharz PB, Stewart C, Tullis E, Durie PR.
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C, Fölsch UR.
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG, Lembcke B, Kirchhoff S, Hilgers R, Creutzfeldt W.
    Dtsch Med Wochenschr; 1988 Jan 08; 113(1):15-7. PubMed ID: 3335192
    [Abstract] [Full Text] [Related]

  • 16. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG, Lembcke B, Göke B, Creutzfeldt W.
    Z Gastroenterol; 1986 Dec 08; 24(12):753-7. PubMed ID: 3548109
    [Abstract] [Full Text] [Related]

  • 17. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study.
    Gouerou H, Dain MP, Parrondo I, Poisson D, Bernades P.
    Int J Pancreatol; 1989 Dec 08; 5 Suppl():45-50. PubMed ID: 2702250
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
    Colombo C, Fredella C, Russo MC, Faelli N, Motta V, Valmarana L, Longo L, D'Orazio C.
    Pancreas; 2009 Aug 08; 38(6):693-9. PubMed ID: 19531972
    [Abstract] [Full Text] [Related]

  • 19. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.
    Proesmans M, De Boeck K.
    Eur J Pediatr; 2003 Nov 08; 162(11):760-3. PubMed ID: 13680386
    [Abstract] [Full Text] [Related]

  • 20. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ, Gelrud A, Munck A, Caras S.
    Adv Ther; 2010 Dec 08; 27(12):895-916. PubMed ID: 21086085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.